Saturday, December 20, 2025
ADVT 
National

First molecular image of COVID-19 variant released

Darpan News Desk The Canadian Press, 04 May, 2021 12:41 AM
  • First molecular image of COVID-19 variant released

The first images of a mutation on a COVID-19 variant of concern have been captured by researchers at the University of British Columbia who say the photos offer some reassurance about how the virus strain may react to current vaccines.

The University of B.C. says the researchers are the first to publish structural images of the mutation found on one portion of the SARS-CoV-2 spike protein.

The spike protein is the part of the virus that opens the door to infection, while the mutation is the change believed partly responsible for the rapid spread of the variant first identified in the United Kingdom.

A team led by Dr. Sriram Subramaniam, professor in the department of biochemistry and molecular biology at UBC's faculty of medicine, found the images show localized placement of the mutation allows it to enter human cells more easily.

The team's analysis, recently published in PLOS Biology, reveals that, once inside, the mutation can still be sidelined by antibodies from current vaccines.

Researchers say that adds to growing evidence that most antibodies generated by existing vaccines are likely to remain effective in preventing mild and severe cases of the B.1.1.7 variant.

The statement says its researchers are also using beams of supercooled electrons in powerful microscopes to visualize the detailed shapes of other COVID-19 variants that are 100,000 times smaller than a pinhead.

"It’s important to understand the different molecular structures of these emerging variants to determine whether they’ll respond to existing treatments and vaccines and ultimately find ways to control their spread more effectively," the statement says.

Variants under study at UBC include those first identified in India, California and South Africa, as well as the P.1 variant of concern first found in Brazil, which along with the B.1.1.7 mutation has accounted for a growing number of infections in Canada.

MORE National ARTICLES

How J&J and AstraZeneca differ from mRNA vaccines

How J&J and AstraZeneca differ from mRNA vaccines
It's the second COVID vaccine to be investigated for a possible link to blood clotting after several European countries temporarily halted use of the Oxford-AstraZeneca vaccine for the same reason last month.

How J&J and AstraZeneca differ from mRNA vaccines

Liberals propose right to a healthy environment

Liberals propose right to a healthy environment
The proposed amendment is included in a new bill introduced in the House of Commons today, C-28, which would strengthen The Canadian Environmental Protection Act.

Liberals propose right to a healthy environment

Health Canada investigating J&J blood clot reports

Health Canada investigating J&J blood clot reports
The clots were observed along with reduced platelet counts making the usual treatment for blood clots, the blood thinner heparin, potentially "dangerous.''

Health Canada investigating J&J blood clot reports

Air Canada, Ottawa agree to $5.9B aid package

Air Canada, Ottawa agree to $5.9B aid package
Thousands of would-be passengers who paid for tickets remained in the lurch at the end of 2020. Air Canada reported it held $2.3 billion in advance ticket sales during the fourth quarter.

Air Canada, Ottawa agree to $5.9B aid package

Over 3200 COVID19 cases over 3 days

Over 3200 COVID19 cases over 3 days
A total of 368 people are currently hospitalized, with 121 of them in intensive care units as half the cases in the province now involve variants of concern, mostly the one first identified in the United Kingdom.

Over 3200 COVID19 cases over 3 days

China, Russia targeting COVID-19 research: Report

China, Russia targeting COVID-19 research: Report
The National Security and Intelligence Committee of Parliamentarians says the pandemic has provided extra incentive for foreign states to target Canada’s health, science and technology sectors, particularly when it comes to vaccine research.

China, Russia targeting COVID-19 research: Report